(Q36830121)

16 August 2017

1 reference

title

Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review (English)

1 reference

16 August 2017

1 reference

Alex Gutierrez-Dalmau

series ordinal

1

1 reference

16 August 2017

Josep M Campistol

series ordinal

2

1 reference

16 August 2017

language of work or name

1 reference

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

67

1 reference

16 August 2017

issue

8

1 reference

16 August 2017

page(s)

1167-1198

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200767080-00006

16 August 2017

exact match

0 references

cites work

Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767080-00006

Human papillomaviruses and non-melanoma skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767080-00006

Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767080-00006

Sirolimus inhibits growth of human hepatoma cells alone or combined with tacrolimus, while tacrolimus promotes cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767080-00006

Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppression

21 January 2018

1 reference

12 December 2020

Effector memory T cells, early metastasis, and survival in colorectal cancer

1 reference

12 December 2020

Risk factors and pathogenesis of posttransplant lymphoproliferative disorders.

1 reference

12 December 2020

Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients

1 reference

12 December 2020

Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation

1 reference

12 December 2020

Predialysis immunosuppression is an independent risk factor for some cancers in renal transplantation

1 reference

12 December 2020

De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population

1 reference

12 December 2020

Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach.

1 reference

12 December 2020

Mechanisms of action and overview of OKT3.

1 reference

12 December 2020

Skin cancers and non-hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study

1 reference

12 December 2020

Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients.

1 reference

12 December 2020

Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil

1 reference

12 December 2020

Role of infectious diseases in human carcinogenesis

1 reference

12 December 2020

Potentiation of renal tumorigenicity by cyclosporine A in streptozotocin diabetic rats

1 reference

12 December 2020

Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis

1 reference

12 December 2020

Basiliximab: a review of its use as induction therapy in renal transplantation

1 reference

12 December 2020

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

1 reference

12 December 2020

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

12 December 2020

Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation

1 reference

12 December 2020

Cancer After Renal Transplantation: The Next Challenge

1 reference

12 December 2020

Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma

1 reference

12 December 2020

The not-so innocent bystander: the microenvironment as a therapeutic target in cancer

1 reference

12 December 2020

Targeting the PI3K-Akt pathway in human cancer: rationale and promise

1 reference

12 December 2020

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

1 reference

12 December 2020

Proceedings: The effect of immunosuppression on cancer

1 reference

12 December 2020

Cancer risk following organ transplantation: a nationwide cohort study in Sweden

1 reference

12 December 2020

Risk of cancer in renal-transplant recipients.

1 reference

12 December 2020

Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey

1 reference

12 December 2020

Effects of oral versus topical administration of cyclosporine on phorbol ester promotion of murine epidermal carcinogenesis.

1 reference

12 December 2020

Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice

1 reference

12 December 2020

Antitumor and immunosuppressive effects of mycophenolic acid derivatives

1 reference

12 December 2020

The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation.

1 reference

12 December 2020

Successful use of sirolimus in a patient with bulky ovarian metastasis of hepatocellular carcinoma after liver transplantation

1 reference

12 December 2020

Ras, PI(3)K and mTOR signalling controls tumour cell growth

1 reference

12 December 2020

The occurrence of residual or recurrent squamous cell carcinomas in organ transplant recipients after curettage and electrodesiccation

1 reference

12 December 2020

Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction

1 reference

12 December 2020

Cancer risk in patients on dialysis and after renal transplantation

1 reference

12 December 2020

Risk of malignancy with long-term immunosuppression in renal transplant recipients.

1 reference

12 December 2020

De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation.

1 reference

12 December 2020

Role of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinoma

1 reference

12 December 2020

Lymphomas after solid organ transplantation: a collaborative transplant study report

1 reference

12 December 2020

Malignant cells, directors of the malignant process: role of transforming growth factor-beta

1 reference

12 December 2020

Malignancies under cyclosporine after kidney transplantation: analysis of a 10-year period

1 reference

12 December 2020

Mechanism of fibrosis in experimental tacrolimus nephrotoxicity

1 reference

12 December 2020

Cancer incidence in a kidney-transplanted population

1 reference

12 December 2020

Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies

1 reference

12 December 2020

Sirolimus conversion for patients with posttransplant Kaposi's sarcoma

1 reference

12 December 2020

Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study

1 reference

12 December 2020

RAD in de novo renal transplantation: comparison of three doses on the incidence and severity of acute rejection

1 reference

12 December 2020

Rapid response to rituximab in a pediatric liver transplant recipient with post-transplant lymphoproliferative disease and maintenance with sirolimus monotherapy

1 reference

12 December 2020

Risk of neoplasia in renal transplant patients.

1 reference

12 December 2020

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting

1 reference

12 December 2020

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study

1 reference

12 December 2020

Accelerated development of spontaneous thymic lymphomas in male AKR mice receiving cyclosporine

1 reference

12 December 2020

Azathioprine and UVA light generate mutagenic oxidative DNA damage

1 reference

12 December 2020

Malignancy after renal transplantation: analysis of incidence and risk factors in 1700 patients followed during a 25-year period

1 reference

12 December 2020

Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation

1 reference

12 December 2020

Strategies for minimizing immunosuppression in kidney transplantation

1 reference

12 December 2020

European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.3. Cancer risk after renal transplantation. Solid organ cancers: prevention and treatment

1 reference

12 December 2020

Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients

1 reference

12 December 2020

Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma

1 reference

12 December 2020

Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction

1 reference

12 December 2020

Risk of cancer with cyclosporine in psoriasis

1 reference

12 December 2020

The Hallmarks of Cancer

1 reference

12 December 2020

Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals.

1 reference

12 December 2020

Activation of p70 ribosomal protein S6 kinase is an essential step in the DNA damage-dependent signaling pathway responsible for the ultraviolet B-mediated increase in interstitial collagenase (MMP-1) and stromelysin-1 (MMP-3) protein levels in huma

1 reference

12 December 2020

Cancer risk after renal transplantation in the nordic countries, 1964-1986

1 reference

12 December 2020

Cancer incidence in a kidney-transplanted population.

1 reference

12 December 2020

Communication: papillomavirus DNA in basal cell carcinomas of immunocompetent patients: an accidental association?TITLE.

1 reference

12 December 2020

Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.

1 reference

12 December 2020

Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients

1 reference

12 December 2020

Mycophenolate mofetil modulates adhesion receptors of the beta1 integrin family on tumor cells: impact on tumor recurrence and malignancy

1 reference

12 December 2020

Triple therapy and incidence of de novo cancer in renal transplant recipients

1 reference

12 December 2020

mTOR-targeted therapy of cancer with rapamycin derivatives

1 reference

12 December 2020

Mycophenolate mofetil increases adhesion capacity of tumor cells in vitro

1 reference

12 December 2020

Early de novo malignancies after kidney transplantation

1 reference

12 December 2020

Malignancies after renal transplantation: the EDTA-ERA registry experience. European Dialysis and Transplantation Association-European Renal Association

1 reference

12 December 2020

In vivo luminescent imaging of cyclosporin A-mediated cancer progression in rats

1 reference

12 December 2020

Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil

1 reference

12 December 2020

Renal transplantation exposes patients with previous Kaposi's sarcoma to a high risk of recurrence

1 reference

12 December 2020

Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients

1 reference

12 December 2020

Study of "de novo" malignancies among greek renal transplant recipients

1 reference

12 December 2020

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

1 reference

12 December 2020

Cancer risk after renal transplantation in Japan

1 reference

12 December 2020

Long-term toxicity of antithymocyte globulin induction may vary with choice of agent: a single-center retrospective study

1 reference

12 December 2020

Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients

1 reference

12 December 2020

Initiation of angiogenic Kaposi's sarcoma lesions

1 reference

12 December 2020

The diagnosis and treatment of posttransplant lymphoproliferative disorders

1 reference

12 December 2020

Mutagenic and cytotoxic effects of immunosuppressive drugs on human lymphocyte cultures.

1 reference

12 December 2020

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

1 reference

12 December 2020

Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group

1 reference

12 December 2020

Long-term survival in renal transplant recipients with graft function

1 reference

12 December 2020

Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials

1 reference

12 December 2020

Effects of corticosteroid use on treatment of solid tumours

1 reference

12 December 2020

Effects of immunosuppressive therapy on the induction of skin tumors by ultraviolet irradiation in hairless mice

1 reference

12 December 2020

Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience

1 reference

12 December 2020

The biochemistry and molecular biology of glucocorticoid-induced apoptosis in the immune system.

1 reference

12 December 2020

Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies

1 reference

12 December 2020

Malignancy after renal transplantation

1 reference

12 December 2020

Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma

1 reference

12 December 2020

Signalling networks that cause cancer

1 reference

12 December 2020

A population-based study of skin cancer incidence and prevalence in renal transplant recipients

1 reference

12 December 2020

Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer

1 reference

12 December 2020

Comparison between tacrolimus and cyclosporine as immunosuppressive agents compatible with tolerance induction by CD4/CD8 blockade

1 reference

12 December 2020

Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report--2005.

1 reference

12 December 2020

Cancer after kidney transplantation in the United States

1 reference

12 December 2020

High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan.

1 reference

12 December 2020

Nitric oxide modulates vascular endothelial growth factor and receptors in chronic cyclosporine nephrotoxicity

1 reference

12 December 2020

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

1 reference

12 December 2020

Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy

1 reference

12 December 2020

Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens

1 reference

12 December 2020

Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression?

1 reference

12 December 2020

Reinstitution of immunosuppression in a renal transplant recipient after remission of Kaposi's sarcoma

1 reference

12 December 2020

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups

1 reference

12 December 2020

Causes of death after renal transplantation

1 reference

12 December 2020

Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia

1 reference

12 December 2020

Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes

1 reference

12 December 2020

Tumors after renal transplantation

1 reference

12 December 2020

Measurement of UVB-Induced DNA damage and its consequences in models of immunosuppression

1 reference

12 December 2020

Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients

1 reference

12 December 2020

Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas

1 reference

12 December 2020

One thousand renal transplants at Belfast City Hospital: post-graft neoplasia 1968-1999, comparing azathioprine only with cyclosporin-based regimes in a single centre

1 reference

12 December 2020

Posttransplantation cutaneous B-cell lymphoma with monoclonal Epstein-Barr virus infection, responding to acyclovir and reduction in immunosuppression.

1 reference

12 December 2020

Anti-tumor activity of mycophenolate mofetil against human and mouse tumors in vivo

1 reference

12 December 2020

Chronic Antigenic Stimulation from the Graft as a Possible Oncogenic Factor after Renal Transplant

1 reference

12 December 2020

Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation

1 reference

12 December 2020

Development of malignancy following lung transplantation.

1 reference

12 December 2020

Enhancement of induction of intestinal adenocarcinomas by cyclosporine in rats given a single dose of N-methyl N-nitrosourea.

1 reference

12 December 2020

Stimulation of transforming growth factor-beta 1 transcription by cyclosporine

1 reference

12 December 2020

Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals

1 reference

12 December 2020

Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer

1 reference

12 December 2020

The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway

1 reference

12 December 2020

Increased incidence of malignancy during chronic renal failure

1 reference

12 December 2020

Molecular aspects of T- and B-cell function in uremia

1 reference

12 December 2020

Human papillomavirus infections in skin cancers

1 reference

12 December 2020

Cancer and survival after cadaveric donor renal transplantation

1 reference

12 December 2020

Malignant neoplasm in kidney transplantation.

1 reference

12 December 2020

Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin

1 reference

12 December 2020

Malignancy after renal transplantation: incidence and role of type of immunosuppression

1 reference

12 December 2020

The appearance of Kaposi sarcoma during corticosteroid therapy

1 reference

12 December 2020

The immunosuppressive drug mycophenolate mofetil impairs the adhesion capacity of gastrointestinal tumour cells.

1 reference

12 December 2020

Faith supported by reason: mechanistic support for the use of polyclonal antibodies in transplantation

1 reference

12 December 2020

TOR signaling in growth and metabolism

1 reference

12 December 2020

Skin cancer following transplantation: the Israel Penn International Transplant Tumor Registry experience

1 reference

12 December 2020

Single-center experience with cyclosporine therapy for kidney transplantation: analysis of a twenty-year period in 1200 patients.

1 reference

12 December 2020

Molecular mechanisms of virus-induced carcinogenesis: the interaction of viral factors with cellular tumor suppressor proteins

1 reference

12 December 2020

A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group.

1 reference

12 December 2020

Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study

1 reference

12 December 2020

Immunosuppressive therapy. The relation between clinical response and immunologic competence

1 reference

12 December 2020

Rituximab and rapamycin for posttransplant lymphoproliferative disease treatment: report of three cases

1 reference

12 December 2020

Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 cases

1 reference

12 December 2020

Transplantation--a medical miracle of the 20th century

1 reference

12 December 2020

Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients

1 reference

12 December 2020

Calcineurin inhibitors in renal transplantation: what is the best option?

1 reference

12 December 2020

Successful renal retransplantation after post-transplant lymphoproliferative disease

1 reference

12 December 2020

Impressive regression of primary liver cancer after treatment with sirolimus

1 reference

12 December 2020

Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect

1 reference

12 December 2020

High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients

1 reference

12 December 2020

Anti-rejection drug treatment increases basal cell carcinoma burden in Ptch1+/- mice

1 reference

12 December 2020

Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression

1 reference

12 December 2020

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

12 December 2020

The risk of ano-genital malignancies in dialysis and transplant patients.

1 reference

12 December 2020

Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression

1 reference

12 December 2020

Glucocorticoid hormones reduce the expression of major histocompatibility class I antigens on human epithelial cells

1 reference

12 December 2020

Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients

1 reference

12 December 2020

Safety of mycophenolate mofetil versus azathioprine in renal transplantation: a systematic review

1 reference

12 December 2020

VEGF receptor signaling in tumor angiogenesis

1 reference

12 December 2020

Management of Epstein-Barr virus-induced post-transplant lymphoproliferative disease in recipients of solid organ transplantation

1 reference

12 December 2020

The effect of immunosuppression on pre-existing cancers

1 reference

12 December 2020

Interference of glucocorticoids with apoptosis signaling and host-tumor interactions

1 reference

12 December 2020

Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation

1 reference

12 December 2020

Efficacy of conversion to sirolimus in posttransplantation Kaposi's sarcoma

1 reference

12 December 2020

Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients.

1 reference

12 December 2020

The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo

1 reference

12 December 2020

Malignant disease in patients with long-term renal transplants

1 reference

12 December 2020

Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients

1 reference

12 December 2020

Chapter 8: Human papillomavirus and skin cancer.

1 reference

12 December 2020

Molecular and biological properties of vascular endothelial growth factor

1 reference

12 December 2020

Expression of transforming growth factor beta (TGF-beta) may contribute, in part, to the variations in histogenesis and the prevalence of peritoneal dissemination in human gastric carcinoma

1 reference

12 December 2020

Complete remission of postransplant lung metastases from hepatocellular carcinoma under therapy with sirolimus and mycophenolate mofetil

1 reference

12 December 2020

Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy

1 reference

12 December 2020

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

12 December 2020

Sirolimus for Kaposi's sarcoma in renal-transplant recipients

1 reference

12 December 2020

Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma

1 reference

12 December 2020

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

1 reference

12 December 2020

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

1 reference

12 December 2020

Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate

1 reference

12 December 2020

Does regressed posttransplantation Kaposi's sarcoma recur following reintroduction of immunosuppression?

1 reference

12 December 2020

Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment

1 reference

12 December 2020

Pharmacokinetics and receptor-mediated pharmacodynamics of corticosteroids

1 reference

12 December 2020

Cyclosporin-A suppresses p53-dependent repair DNA synthesis and apoptosis following ultraviolet-B irradiation

1 reference

12 December 2020

Non-melanoma skin cancers and glucocorticoid therapy

1 reference

12 December 2020

Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment

1 reference

12 December 2020

Increased ultraviolet radiation-induced skin cancers in cyclosporine-treated mice

1 reference

12 December 2020

Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy

1 reference

12 December 2020

Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials

1 reference

12 December 2020

Influence of immunosuppression on the prevalence of cancer after kidney transplantation

1 reference

12 December 2020

Renal transplant recipients with graft survival longer than 20 years: report on 107 cases

1 reference

12 December 2020

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

1 reference

12 December 2020

Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation

1 reference

12 December 2020

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

1 reference

12 December 2020

Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study

1 reference

12 December 2020

Risks of allogeneic hand transplantation

1 reference

12 December 2020

Epidermal dysplasia and cyclosporine therapy in renal transplant patients: a comparison with azathioprine

1 reference

12 December 2020

The risk of cancer from azathioprine as a treatment for multiple sclerosis

1 reference

12 December 2020

Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine.

1 reference

12 December 2020

Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton

1 reference

12 December 2020

Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation

1 reference

12 December 2020

Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis

1 reference

12 December 2020

Infectious agents and cancer: criteria for a causal relation

1 reference

12 December 2020

Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens

1 reference

12 December 2020

A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients

1 reference

12 December 2020

Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry

1 reference

12 December 2020

Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study.

1 reference

12 December 2020

Clinical course of malignancies in renal transplant recipients

1 reference

12 December 2020

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

1 reference

12 December 2020

Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?

1 reference

12 December 2020

Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients

1 reference

12 December 2020

Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses

1 reference

12 December 2020

10.2165/00003495-200767080-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

16 August 2017

1020986267

0 references

1 reference